{"id":"https://openalex.org/W2249986218","doi":"https://doi.org/10.1200/jco.2015.33.3_suppl.240","title":"A phase I/II multicenter study of the chimeric monoclonal antibody NEO102 (NPC-1C) in adults with refractory pancreatic (PC) and colorectal cancer (CC).","display_name":"A phase I/II multicenter study of the chimeric monoclonal antibody NEO102 (NPC-1C) in adults with refractory pancreatic (PC) and colorectal cancer (CC).","publication_year":2015,"publication_date":"2015-01-20","ids":{"openalex":"https://openalex.org/W2249986218","doi":"https://doi.org/10.1200/jco.2015.33.3_suppl.240","mag":"2249986218"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2015.33.3_suppl.240","doi":"https://doi.org/10.1200/jco.2015.33.3_suppl.240","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.3_suppl.240","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014809735","display_name":"Muhammad Shaalan Beg","orcid":"https://orcid.org/0000-0002-3754-6627","observed_orcids":["https://orcid.org/0000-0002-3754-6627"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Muhammad Shaalan Beg","raw_affiliation_strings":["Division of Hematology/Oncology, The University of Texas Southwestern Medical Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, The University of Texas Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074731037","display_name":"Michael Andrew Morse","orcid":"https://orcid.org/0000-0002-5725-4533","observed_orcids":["https://orcid.org/0000-0002-5725-4533"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Morse","raw_affiliation_strings":["Duke University Medical Center, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070734531","display_name":"Sandip Pravin Patel","orcid":"https://orcid.org/0000-0002-8387-4840","observed_orcids":["https://orcid.org/0000-0002-8387-4840","https://orcid.org/0000-0002-4954-4944"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandip Pravin Patel","raw_affiliation_strings":["Duke University Medical Center, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059747639","display_name":"Sharon A. Mavroukakis","orcid":"https://orcid.org/0000-0003-4697-6474","observed_orcids":["https://orcid.org/0000-0003-4697-6474"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharon Mavroukakis","raw_affiliation_strings":["Precision Biologics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Biologics, Rockville, MD","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047349001","display_name":"Melony A. Beatson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melony A. Beatson","raw_affiliation_strings":["Precision Biologics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Biologics, Rockville, MD","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073536820","display_name":"Philip Martin Arlen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip M. Arlen","raw_affiliation_strings":["Precision Biologics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Biologics, Rockville, MD","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060219345","display_name":"Nilofer Saba Azad","orcid":"https://orcid.org/0000-0002-9613-3988","observed_orcids":["https://orcid.org/0000-0002-9613-3988"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nilofer Saba Azad","raw_affiliation_strings":["Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"3_suppl","first_page":"240","last_page":"240"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.7103999853134155,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.7103999853134155,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.20649999380111694,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.02449999935925007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-monoclonal-antibody","display_name":"chimeric monoclonal antibody","score":0.9900000095367432},{"id":"https://openalex.org/keywords/muc5ac","display_name":"MUC5AC","score":0.9589999914169312},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.8159999847412109},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/refractory-cancer","display_name":"refractory cancer","score":0.9509999752044678},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9739999771118164},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7540000081062317},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8690000176429749},{"id":"https://openalex.org/keywords/hyperbilirubinemia","display_name":"hyperbilirubinemia","score":0.847000002861023},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.8769999742507935},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.734000027179718},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5830000042915344},{"id":"https://openalex.org/keywords/immune-correlates","display_name":"immune correlates","score":0.5950000286102295},{"id":"https://openalex.org/keywords/hamas","display_name":"Hamas","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.930935263633728},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6417256593704224},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5877355933189392},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5838775634765625},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4902983009815216},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.48471999168395996},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.46767956018447876},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4562349319458008},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4244653582572937},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4160114526748657},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41312265396118164},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.37520310282707214},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36871176958084106},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24370044469833374},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2380637526512146},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2015.33.3_suppl.240","doi":"https://doi.org/10.1200/jco.2015.33.3_suppl.240","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.3_suppl.240","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8500000238418579}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2013645270","https://openalex.org/W2484253333","https://openalex.org/W2908221867","https://openalex.org/W2590430429","https://openalex.org/W2806818170","https://openalex.org/W2591494309","https://openalex.org/W2589453705","https://openalex.org/W4256507697","https://openalex.org/W2890337375","https://openalex.org/W2082709824"],"abstract_inverted_index":{"240":[0],"Background:":[1],"NPC-1C":[2],"(NEO102)":[3],"is":[4,31,52,140,217,252,261,299,317],"a":[5,12,53,256,305],"novel":[6],"chimeric":[7],"monoclonal":[8],"antibody":[9],"that":[10],"recognizes":[11],"variant":[13],"form":[14],"of":[15,29,41,48,64,108,225,227,271,277,291],"MUC5AC":[16],"expressed":[17],"specifically":[18],"by":[19,192],"human":[20],"pancreatic":[21,127,295,315],"(P)":[22],"and":[23,44,61,106,118,128,136,162,172,205,285,296],"colorectal":[24],"(CC)":[25],"tumors.":[26],"The":[27,99,167],"mechanism":[28],"action":[30],"through":[32],"Antibody-dependent":[33],"cell-mediated":[34],"cytotoxicity":[35],"(ADCC).":[36],"We":[37],"are":[38,67,132,147],"presenting":[39],"results":[40,265],"dose":[42,150,170,175],"escalation":[43],"preplanned":[45],"expansion":[46,62],"cohort":[47,63],"NEO-102.":[49],"Methods:":[50],"This":[51],"Phase":[54,288],"Ib/IIa,":[55],"open":[56],"label,":[57],"multicenter":[58],"clinical":[59,115,272],"trial":[60,320],"NEO102.":[65,109],"Patients":[66],"preselected":[68],"based":[69,274],"on":[70,275],"an":[71],"Immunuhistochemistry":[72],"(IHC)":[73],"companion":[74],"diagnostic":[75],"assay.":[76],"Antigen":[77],"expression":[78],"cut":[79],"off":[80],"was":[81,87,102,177],"set":[82],"at":[83,155,179],"20%":[84],"expression.":[85],"NEO102":[86,251,267,292,309],"administered":[88],"every":[89,96],"2":[90],"weeks":[91],"IV":[92],"with":[93,250,255,266,283,310],"tumor":[94],"assessments":[95],"8":[97],"weeks.":[98],"primary":[100],"objective":[101],"to":[103],"determine":[104],"safety":[105,258],"tolerability":[107],"Secondary":[110],"objectives":[111],"include":[112],"overall":[113],"survival,":[114],"benefit,":[116],"pharmacokinetics":[117],"explore":[119],"the":[120,200,211],"immunologic":[121],"correlates.":[122],"Results:":[123],"Twenty-six":[124],"patients":[125,184,282],"(3":[126],"23":[129],"colon":[130,297],"cancer)":[131],"evaluable":[133],"for":[134,186],"toxicity":[135],"response.":[137],"Median":[138],"age":[139],"55":[141],"(32":[142],"-":[143,221],"68)":[144],"years,":[145],"14":[146],"male.":[148],"Two":[149],"limiting":[151],"toxicities":[152],"were":[153,236],"experienced":[154],"4.0":[156],"mg/kg:":[157],"grade":[158,163],"3":[159,164],"hyperbilirubinemia":[160],"(n=4)":[161],"anemia":[165],"(n=1).":[166],"maximum":[168],"tolerated":[169,254],"(MTD)":[171],"recommended":[173],"phase-2":[174],"(RP2D)":[176],"established":[178],"3.0":[180,262],"mg/kg.":[181,263],"Of":[182,231],"12":[183],"evaluated":[185],"response,":[187],"5":[188],"demonstrated":[189,269],"stable":[190],"disease":[191,278],"RECIST":[193],"(42%;":[194],"4":[195],"CC,":[196],"1":[197,206],"P)":[198],"after":[199,210],"first":[201],"course":[202,213],"(Day":[203,214],"57)":[204],"PC":[207,284],"had":[208],"SD":[209],"second":[212],"114).":[215],"OS":[216],"4.5+":[218],"months":[219],"(1+":[220],"13.5+),":[222],"median":[223],"duration":[224],"treatment":[226],"74+":[228],"days":[229],"(36-133).":[230],"those":[232],"screened,":[233],"60-70%":[234],"tumors":[235],"IHC":[237],"positive.":[238],"Immune":[239],"correlates":[240],"(including":[241],"cytokine":[242],"profile,":[243],"HAMA)":[244],"will":[245],"be":[246],"presented.":[247],"Conclusions:":[248],"Treatment":[249],"well":[253],"manageable":[257],"profile.":[259],"RP2D":[260],"Preliminary":[264],"have":[268],"signs":[270],"activity":[273],"stabilization":[276],"in":[279,294,313],"heavily":[280],"pretreated":[281],"CC.":[286],"A":[287],"II":[289],"study":[290,307],"monotherapy":[293],"cancer":[298,316],"now":[300],"enrolling":[301],"patients.":[302],"In":[303],"addition,":[304],"combination":[306],"using":[308],"cytotoxic":[311],"chemotherapy":[312],"metastatic":[314],"underway.":[318],"Clinical":[319],"information:":[321],"NCT01040000.":[322]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2016-06-24T00:00:00"}